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Abstract
Traumatic brain injury (TBI), ranging from mild concussion to severe penetrating wounds, can 
involve brain regions that contain damaged or lost synapses in the absence of neuronal death. 
These affected regions significantly contribute to sensory, motor and/or cognitive deficits. Thus, 
studying the mechanisms responsible for synaptic instability and dysfunction is important for 
protecting the nervous system from the consequences of progressive TBI. Our controlled cortical 
impact (CCI) injury produces ~20% loss of synapses and mild changes in synaptic protein levels 
in the CA3-CA1 hippocampus without neuronal losses. These synaptic changes are associated 
with functional deficits, indicated by > 50% loss in synaptic plasticity and impaired learning 
behavior. We show that the receptor tyrosine kinase EphB3 participates in CCI injury-induced 
synaptic damage, where EphB3−/− mice show preserved long-term potentiation and hippocampal-
dependent learning behavior as compared with wild type (WT) injured mice. Improved synaptic 
function in the absence of EphB3 results from attenuation in CCI injury-induced synaptic losses 
and reduced D-serine levels compared with WT injured mice. Together, these findings suggest that 
EphB3 signaling plays a deleterious role in synaptic stability and plasticity after TBI.
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1. Introduction
Every year millions of people suffer the devastating consequences of a traumatic brain injury 
(TBI) (Centers for Disease Control and Prevention (CDC), 2013; Hyder et al., 2007). TBI is 
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a complex disorder that leads to profound deficits in neurological function as a result of 
progressive pathological events. TBI can be categorized as an open or closed head injury 
ranging from mild to severe pathology. At the site of impact, moderate to severe brain 
injuries usually include vascular damage, cell loss, axonal and synaptic damage; however, 
synaptic dysfunction in the absence of cell loss has also been observed in more distal regions 
(Kotapka et al., 1991; Lowenstein et al., 1992). Moreover, synaptic damage is thought to be 
a major contributor to chronic neurological symptoms following mild concussive injuries 
(Harish et al., 2015; Merlo et al., 2014). For this reason, it is important to understand the 
mechanisms that regulate synaptic stability and plasticity in the traumatic injured brain.
Learning and memory deficits are commonly observed impairments following TBI (Lyeth et 
al., 1990; Schwarzbach et al., 2006; Witgen et al., 2005). Consolidation of short- and long-
term memory is attributed to activity-dependent changes in synaptic strength (i.e. synaptic 
plasticity) in the hippocampus. NMDAR activation is critical for synaptic plasticity, as its 
activation is known to regulate glutamatergic receptor density in the post-synaptic 
membrane, bouton size, and synaptic strength (Adams et al., 2001; Hardingham and Bading, 
2010; Hunt and Castillo, 2012). Recently, D-serine has been shown to function as the 
endogenous co-agonist for NMDARs, and together with glutamate is essential for synaptic 
plasticity, learning and memory (Balu et al., 2014; Han et al., 2015; Mothet et al., 2000; 
Wolosker et al., 1999a). D-serine is synthesized through the racemization of L-serine by the 
enzyme serine racemase (Wolosker et al., 1999b), though the mechanisms that regulate D-
serine conversion and release after TBI have yet to be explored. What is known is that 
excessive activation of NMDARs is thought to play a key role in TBI pathology, and 
underlies excitotoxic cell death (Faden et al., 1989; Hardingham et al., 2002). It is less clear 
whether sub-excitotoxic activation of NMDAR by D-serine after TBI can lead to synaptic 
damage.
Receptor tyrosine kinases are also associated with synaptic membranes and play important 
roles in regulating synaptic formation and function. In particular, Eph receptors (Ephs) have 
been shown to stabilize post-synaptic densities, regulate excitatory synaptic numbers, 
glutamate receptor transport, and synaptic plasticity (Antion et al., 2010; Grunwald et al., 
2004; Henkemeyer et al., 2003; Hruska et al., 2015; Rodenas-Ruano et al., 2006). Both Ephs 
and their ligands (i.e. ephrins) are membrane bound and can elicit bidirectional signals upon 
interactions of pre- and post-synaptic membranes (Aoto and Chen, 2007; Klein, 2009; 
Pasquale, 2008). Astrocytes can also interact with neuronal components of the synapse in 
what is known as the tripartite synapse to regulate synapse formation and plasticity (Halassa 
et al., 2007; Perea et al., 2009). Astroglial release of glutamate and D-serine can alter 
synaptic function, where gliotransmitter levels in the synapse can fine-tune excitatory 
postsynaptic potentials (Araque et al., 2014; Gundersen et al., 2015; Halassa et al., 2007). 
Moreover, ephrinB3 interaction with EphB3 and EphA4 in astrocytes is known to influence 
hippocampal synaptic plasticity through regulation of D-serine synthesis and release (Zhuang 
et al., 2010). It is therefore important to understand the role of Eph-mediated signaling 
events following TBI, specifically the contribution to D-serine release and synaptic function.
Our findings suggest that elevated levels of D-serine after TBI may contribute to progressive 
CNS pathology. We also show that EphB3 negatively regulates excitatory glutamatergic 
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synaptic stability and plasticity after moderate TBI, as observed by decreased D-serine 
levels, improved synaptic stability and enhanced long-term potentiation in the absence of 
EphB3.
2. Materials & methods
2.1. Animals
EphB3 knockout (EphB3−/−) mutant mice were bred on a C57Bl/6 background as previously 
described (Henkemeyer et al., 1996; Orioli et al., 1996). All procedures were performed on 
both wild type (WT) and EphB3−/− male mice 2–4 months of age and approved by the 
University of Miami Institutional Animal Care and Use Committee.
2.2. Controlled cortical impact (CCI) injury
Mice were initially anesthetized with a ketamine/xylazine cocktail and placed on a heating 
pad. Mice were placed in a stereotaxic frame, where they remained until the end of the 
procedure. The head was shaved and the skull was exposed through a skin incision. A 5 mm 
craniotomy was made over the right parieto-temporal cortex without disturbing the dura, 
with the epicenter coordinates at bregma: −2.0 mm; lateral: −2.5 mm. Mice were then 
subjected to a moderate CCI at a velocity of 4 m/s, 0.50 mm depth and 150 ms duration 
using an eCCI-6.0 device (Custom Design & Fabrication, Richmond, VA). The CCI consists 
of a pressurized metal piston delivering a blow at the aforementioned parameters directly 
onto the dura of the brain producing mechanical strain forces similar to those observed in 
human TBI (Osier et al., 2015). Following the impact, the skin was closed using 5-0 Vicryl 
synthetic absorbent sutures, and animals were placed into a clean cage on a heating pad until 
recovery from anesthesia. Mice received 0.9% saline and analgesic (Buprenorphine) 
injections and monitored bi-daily for one week.
2.3. Stereological cell and neuronal counts
Mice were anesthetized and perfused with 0.1 M phosphate buffer and 4% 
paraformaldehyde (PFA). Brains were dissected and serially cryo-sectioned (Leica CM 
1900, Leica Biosystems Inc., Buffalo Grove, IL) at 15 µm/section from bregma −1.4 to −2.2 
for a total tissue thickness ~1500 µm. For total hippocampal cell counts and regional 
volumetric analysis, hematoxylin and eosin staining was performed on serial sections. Micro 
Bright Field StereoInvestigator software package (MBF Bioscience, Williston, VT) was used 
to contour the dentate gyrus, hilus, CA3 and CA1 areas at 10× magnification. After 
contouring, a grid of 100 × 100 µm2 was placed over each region of interest and 
hematoxylin-stained nuclei within a random sampling box of 50 × 50 µm2 was counted 
using the optical fractionator at 63 × magnification for unbiased determination of cell 
number. Investigators were blind to experimental group. For neuronal counts, neuronal 
labeling with NeuN antibody (Cell Signaling, Beverly, MA) and DAPI was performed on 
serial sections. Randomized images of each hippocampal region were acquired at 40 × 
magnification using an Olympus BX50 microscope. ImageJ software was utilized to 
quantify DAPI-positive and NeuN-positive cells within the dentate granule cell, CA1 and 
CA3 pyramidal cell layers. Investigators were blind to experimental group.
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2.4. Transmission electron microscopy (TEM)
Mice were anesthetized and perfused with 2% PFA/2% glutaraldehyde in 0.1 M phosphate 
buffer. Brains were dissected, embedded in chicken albumin agar and cut into 500 µm 
sections using a motorized vibrating-blade microtome (Leica VT1000s, Leica Biosystems 
Inc., Buffalo Grove, IL). CA1 hippocampal regions were dissected, cut into 1 mm2 pieces, 
and further post-fixed with 3% EM grade glutaraldehyde. Ultrathin tissue sections were 
stained with conventional osmium-uranium-lead method containing 1% ethanolic 
phosphotungstic acid (EPTA). The CA1 hippocampus was visualized using a Philips CM-10 
TEM operating at 80 kV. Sections were placed on a grid and non-overlapping randomized 
photographs (>20/section) were taken throughout the entirety of CA1 stratum radiatum. 
Photographs were digitized, and an investigator blinded to experimental group quantified 
synapses manually. The inclusion criteria for excitatory synapses included the presence of 
pre- and post-synaptic membranes with a discernible synaptic cleft, presence of asymmetric 
pre- and post-synaptic densities, and presence of synaptic vesicles at the presynaptic 
terminal as described previously (DeFelipe et al., 1999; Mayhew, 1996). Pre- and post-
synaptic densities from quantified synapses were measured for synaptic area and length 
using ImageJ.
2.5. Western blot analyses
Ipsilateral hippocampal tissues from sham and CCI injured mice were homogenized in RIPA 
buffer with protease and phosphatase inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and 
benzonase nuclease (Millipore Corporation, Billerica, MA) and mixed by rocking at 4 °C for 
at least 15 min. Tissues were centrifuged, supernatant was recovered, samples were diluted 
and standardized to protein concentrations. Protein samples were separated on 8–10% SDS-
PAGE gel and transferred to a nitrocellulose membrane. Membranes were then blocked with 
5% milk or 5% BSA in 0.1 M phosphate buffer with 0.1% Tween-20 for 1 h at room 
temperature (RT) and incubated overnight at 4 °C with primary antibodies. Membranes were 
incubated for 1 h at RT with HRP-conjugated secondary antibodies (Jackson 
Immunoresearch Laboratories, West Grove, PA). Bands were visualized using SuperSignal 
substrate (ThermoScientific, Pittsburg, PA). The following primary antibodies were used: 
anti-GluR1, anti-NR1, anti-NR2B (EMD Millipore, Billerica, MA), anti-GFAP (BD 
Biosciences, San Jose, CA), anti-SNAP25, anti-SNAP23 (ABCAM, Cambridge, MA) and 
anti-β-tubulin (Sigma-Aldrich, St. Louis, MO) antibodies. ImageJ was used to perform 
density analysis. Protein measurements were standardized to β-tubulin and normalized to 
average WT sham signals.
2.6. Intra-hippocampal infusion of ephrinB3
Alzet pumps (1003D, Alzet, Cupertino, CA) were preloaded with 112 µg/kg/day pre-
clustered ephrinB3-Fc or Fc-only, while other experiments used 840 µg/kg/day D-serine or 
vehicle. Briefly, loaded pumps were connected to a brain infusion catheter and placed in 0.1 
M phosphate buffer at 37 °C overnight (Theus et al., 2014). After the CCI injury, the 
infusion device was attached to the stereotactic holder and the tip of the cannula was 
lowered 1.7 or 2.0 mm into the hippocampus or lateral ventricle, respectively. The infusion 
device was secured to the skull using Loctite 454 prism gel (Henkel Corp. Rocky Hill, CT). 
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The pump was then placed under the skin in the back of the neck and the incision was closed 
with suture. Mice were placed in clean heated cages to recover.
2.7. Chemiluminescent assay
Mice were anesthetized and the ipsilateral hippocampi were immediately dissected and 
homogenized in RIPA buffer with protease and phosphatase inhibitor cocktail and benzonase 
nuclease and incubated by rocking at 4 °C for at least 15 min. Tissues were centrifuged, 
supernatants were recovered, and samples were diluted and standardized to protein 
concentrations. D-serine was measured by a chemiluminescent assay as previously described 
(Wolosker et al., 1999b; Zhuang et al., 2010). A 10 µl sample was mixed with 100 µl of 
medium containing 100 mM Tris-HCl, pH 8.8, 20 units/ml peroxidase, and 8 µM luminol. 
To decrease background signal of luminal, 10 µl of D-amino acid oxidase (DAAO) (75 
units/ml) were added after a 15 min delay. Chemiluminescence kinetics was recorded for 4 
min at RT with a FLUOstar Omega microplate reader (BMG Labtech, Ortenberg, Germany). 
The concentration of D-serine in each sample was compared to a standard curve. The linear 
range was 50–1000 pmol of D-serine in the sample and the detection limit was 30 pmol. 
Glutamate was measured using Amplex Red Glutamic Acid/Glutamate Oxidase Assay kit 
(Molecular Probes, Eugene, OR) following the manufacturer’s protocol. Fluorescence was 
measured in a FLUOstar Omega microplate reader using excitation in the range of 530–560 
nm and emission detection at 590 nm. To correct for background fluorescence, the values 
were subtracted from control well values (i.e. no glutamic acid).
2.8. Electrophysiology
2.8.1. In vivo electrophysiology—Mice were anesthetized with urethane (1.5 g/kg) and 
placed on a stereotaxic frame. A 25 µm concentric platinum-iridium bipolar stimulation 
electrode and platinum-iridium recording electrode were inserted through a craniotomy site 
at bregma: −2.0 mm; lateral: −2.0 mm; depth: 1.4 mm (stimulation electrode) and bregma: 
−1.8 mm; lateral: −1.4 mm; depth: −1 to −1.5 mm (recording electrode). Concentric 
platinum-iridium bipolar stimulation electrodes (tip diameter 25 µm, FHC, Bowdoin, ME) 
were placed in the Schaffer Collaterals and a recording glass micropipette filled with 150 
mM sodium chloride (1–3 MΩ) was placed in the CA1 stratum radiatum. Field potentials 
were recorded and converted to digital using an Axoclamp 2B amplifier, Axon Instruments 
Digidata 1322A analog-to-digital converter, and Clampex (Axon Instruments) software for 
data acquisition and analysis. Input-output (I/O) curves were generated by delivering 
electrical monophasic pulses to the CA3 Schaffer Collaterals from a Grass S88 stimulator 
and S1U5 stimulus isolation unit, and measuring the field-excitatory post-synaptic potential 
(fEPSP) at increasing stimulus intensities. Stimulus intensities were then adjusted to give 
fEPSP amplitude at 45–55% of the maximum. A stable baseline fEPSP slope was recorded 
at a rate of 1/60 s for at least 30 min. A paired-pulse facilitation protocol was run using 
inter-pulse intervals of 20 ms, 40 ms, and 80 ms. Long term potentiation (LTP) was induced 
with high-frequency stimulation (HFS, 2 × 100 Hz, 1 s trains, 20 s inter-train interval). Post-
HFS fEPSPs were recorded for at least 60 min. Post-tetanus fEPSP slopes were expressed as 
a percentage of the average fEPSP slope from the baseline recordings.
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2.8.2. In vitro electrophysiology—Mice were anesthetized using isoflurane and 
decapitated. Brains rapidly removed, and to reduce tissue damage, were quickly immersed in 
oxygenated ice-cold fresh high sucrose containing artificial cerebrospinal fluid (high 
sucrose-aCSF): 100 mM sucrose, 60 mM NaCl, 3 mM KCl, 1.25 mM NaH2PO4, 28 mM 
NaHCO3, 0.5 mM CaCl2, 7 mM MgCl2, 0.6 mM ascorbic acid, and 5 mM glucose 
equilibrated with 95% O2:5% CO2. Brains received a mid-sagittal hemisection and the 
ipsilateral hippocampi were carefully dissected from the overlying cortex. The hippocampi 
were mounted on agarose blocks, and cross-sectioned into 300 µm slices with a motorized 
vibrating-blade microtome (Leica VT1000s, Leica Biosystems Inc., Buffalo Grove, IL). 
Slices were gradually transferred from high sucrose-aCSF to a holding chamber containing 
50% high sucrose-aCSF/50% aCSF. aCSF contained: 125 mM NaCl, 2.5 mM KCl, 1.25 mM 
NaH2PO4, 25 mM NaHCO3, 2 mM CaCl2, 1 mM MgCl2, and 25 mM glucose, oxygenated 
with 95% O2:5% CO2 at RT. Slices were allowed to recover for at least 1 h in aCSF at RT 
before transfer to a submersion-type recording chamber perfused with aCSF oxygenated 
with 95% O2:5% CO2 at 32 °C. Field potentials were recorded using an Axoclamp 2B 
amplifier, Axon Instruments Digidata 1400 analog-to-digital converter, and Clampex 
software for data acquisition and analysis. The recording protocol was the same as used 
during in vivo electrophysiological recordings.
2.9. Fear conditioning test
The fear conditioning apparatus consists of a box (30 × 24 × 21 cm, Coulbourn Instruments, 
Whitehall, PA) with an electric grid floor (0.8 cm spacing, 4.8 mm diameter rods). Mice 
were placed in the box for habituation for 600 s. On the second day of the paradigm, mice 
were placed back in the box for 120 s followed by a 30 s tone (85 dB, 2 kHz) with a 0.7 mA 
foot shock delivered through the grid floor during the last 2 s of the tone. The animals 
remained in the box for an additional 60 s after the shock for a total duration of 210 s of 
training. At 24 h after training, mice were placed in the same box and freezing behavior was 
measured for 300 s to assess contextual fear conditioning. At 1 h after contextual fear 
assessment, cue fear conditioning was assessed by placing mice in a chamber with different 
wall coloration, lighting and scent and measuring freezing behavior for 360 s during which 
the tone (85 dB, 2 kHz) was delivered for the last 180 s. The box was cleaned with 70% 
EtOH and an enzymatic cleaner between animals. Freezing behavior was quantified using 
video-based analysis software (FreezeFrame, Coulbourn Instruments, Whitehall, PA).
2.10. Statistical analyses
Data were graphed using GraphPad Prism (GraphPad Inc., SanDiego, CA). Comparisons 
between WT sham and EphB3−/− sham, WT sham and WT CCI, or EphB3−/− sham and 
EphB3−/− CCI injured mice were measured. Student’s two-tailed t-test was used for 
comparison of two experimental groups. One-way ANOVA or two-way ANOVA was used 
for comparison of more than two groups, followed by Bonferroni post-hoc correction. 
Kolmogorov-Smirnov (K-S) test was used to analyze the distribution of synaptic density 
areas and width in combination with Kruskal-Wallis test in the TEM studies. For 
hippocampal electrophysiological recordings two-way ANOVA and repeated measures 
ANOVA with Bonferroni post-hoc correction were used. Data is represented as mean value 
± standard error of the mean (SEM).
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3. Results
3.1. A CCI injury model to examine synaptic dysfunction without hippocampal neuronal 
loss
To examine the effects of traumatic brain injury (TBI) on synaptic stability and function, we 
took advantage of a well-described controlled cortical impact (CCI) injury model (Edward 
Dixon et al., 1991; Osier et al., 2015; Smith et al., 1995; Theus et al., 2014). While other 
TBI models exist, CCI injury allows for accurate replication of biomechanics similar to 
human TBI (Peña et al., 2005; Xiong et al., 2013; Zhang et al., 2014), and can be adapted to 
different injury severities depending on the experimental paradigm (BRODY et al., 2007; 
Chen et al., 2014; Saatman et al., 2006; Assis-Nascimento et al., 2016). To examine synaptic 
dysfunction in the TBI environment, we established a moderate mouse controlled cortical 
impact (CCI) injury model where hippocampal synaptic damage is independent of neuronal 
loss. Hematoxylin and eosin (H&E) stained CCI injured wild type (WT) tissues showed 
substantial cortical damage at 7 days post-CCI injury (dpi) as compared with sham controls 
(Fig. 1A, B); however, no overt hippocampal damage was observed (Fig. 1B) nor at 30 dpi 
(not shown). High magnification of CA1 pyramidal neurons (CA1) of the hippocampus in 
Thy-1-YFP reporter mice also showed no visible neuronal damage at 7 dpi (Fig. 1A’, B’). 
Furthermore, significant upregulation in GFAP immunoreactivity was observed in the CA1 
hippocampus after CCI injury but not in sham injured mice (Fig. 1C – D), which is 
consistent with activating hippocampal injury cascades that lead to hypertrophic astrocytes 
but no neuronal loss after brain injury (Burda et al., 2016; Chen et al., 2014; Laird et al., 
2008).
To determine whether CCI injury affects synaptic function at 7 dpi, we measured CA3-CA1 
hippocampal field excitatory post-synaptic potentials (fEPSPs) and long-term potentiation 
(LTP) in vivo. CCI injury led to a significant deficit in synaptic recruitment at higher 
stimulus intensities, as observed by a significant difference in the input/output (I/ O) curve at 
stimulus intensities of 20 and 30 µA between sham and CCI injured mice (p = 0.0313 and p 
= 0.0162, respectively; Fig. 1E). In addition, examination of LTP showed a significant 
reduction in the CA3-CA1 fEPSP slope in CCI injured mice (p = 0.0132) when compared 
with sham controls (Fig. 1F; n = 4–5/group). We next examined hippocampal-dependent 
learning and memory using a fear-conditioning paradigm known to detect deficits after TBI 
(Titus et al., 2013). No difference was observed in habituation and baseline training; 
however, WT sham mice displayed significant contextual and cued freezing behavior that 
was not observed in CCI injured mice (p < 0.001 and p = 0.0287, respectively; Fig. 1G; n = 
7/group). Together, these findings demonstrate that CCI injury results in significant synaptic 
dysfunction and learning deficits even in the absence of gross hippocampal tissue damage.
To evaluate whether synaptic deficits are independent of hippocampal cell loss or atrophy, 
we quantified the number of CA1 pyramidal cells, CA3 pyramidal cells and dentate granule 
cells (DGC) at 7 dpi using non-biased stereology on hematoxylin stained (Fig. 1H; n = 5/ 
group) and anti-NeuN immunolabeled (Fig. 1I; n = 3/group) hippo-campal tissues in regions 
directly ventral to the injury epicenter. We also performed tissue volume analysis at 7 dpi 
between groups using non-biased stereology (SFig. 1A–D; n = 5/group). For all analyses, we 
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observed no significant difference in the number or volume of CA1 or CA3 pyramidal cells 
between sham and CCI injury. We did observe a modest increase in DGC numbers after CCI 
injury as compared with sham counterparts (p = 0.0324; Fig. 1H), but significant difference 
was not observed in the NeuN-positive cells (Fig. 1I), DGC or hilus volumes (SFig. 1C, D). 
Quantitative differences between hematoxylin and anti-NeuN counts likely reflect 
differences in cell identification as previously reported (Zhu et al., 2015), where 
hematoxylin counts where based on morphological criteria while anti-NeuN counts were 
based on nucleated anti-NeuN cell bodies. Together, these findings support a CCI injury 
model where the mechanisms of synaptic damage can be examined independent of neuronal 
death.
3.2. EphB3 levels are increased after CCI injury
EphB3 signaling is known to have a deleterious effect in tissue recovery (Theus et al., 2010, 
2014); however, its effects on synaptic stability and function after CCI injury are still poorly 
defined. To evaluate the role of EphB3 in the injured hippocampus, we first examined 
EphB3 levels in the sham and CCI injured hippocampus at 3 and 7 dpi. Western blot analysis 
showed a significant increase in EphB3 levels at 3 and 7 dpi as compared with sham controls 
(Fig. 2A; n = 4/group), which correspond to the peak periods of synaptic dysfunction. In the 
absence of EphB3 (i.e. EphB3−/− mice)we observed reduced gross cortical damage at 7 dpi 
(Fig. 2C) as compared with WT CCI injury (Fig. 1B) and EphB3−/− sham (Fig. 2B) mice, 
which supports previous findings (Theus et al., 2014). In addition, no overt gross 
hippocampal damage was observed and stereological quantification of cell numbers showed 
no differences in CA1 and CA3 pyramidal cell layers (Fig. 2D) or regional hippocampal 
volumes between sham and CCI injured EphB3−/− mice (SFig. 1A–D; n = 5/group). In the 
injured EphB3−/− hippocampal dentate gyrus (Fig. 2D), we did observe an increase in DGC 
numbers (p = 0.0324) similar to that observed in WT mice after injury (Fig. 1H).
3.3. CCI injury leads to EphB3-dependent synaptic loss in the hippocampus
To begin evaluating hippocampal synaptic damage following CCI injury, we used 
transmission electron microscopy (TEM) to quantify synaptic numbers as well as measured 
pre- and post-synaptic densities in the ipsilateral CA1 stratum radiatum of WT and 
EphB3−/− mice at 7 dpi (Fig. 3; n = 4/group). Tissues were cut into ultrathin sections (Fig. 
3A), the CA1 was dissected and a placed on a grid (Fig. 3B), and non-overlapping 
photographs of EPTA-stained CA1 stratum radiatum were taken (Fig. 3C). We then 
quantified asymmetric (i.e. excitatory) synapses (Mayhew, 1996; Sheng and Kim, 2011) if 
they met the following criteria: apposed pre- and post-synaptic densities, the presence of 
pre-synaptic vesicles and a visually discrete synaptic cleft (Fig. 3D, E). WT CCI injured 
mice showed a significant ~20% reduction (p < 0.001) in synaptic numbers compared with 
sham controls (Fig. 3F). We observed fewer synapses in EphB3−/− sham mice than WT 
sham mice (p < 0.001; Fig. 3F), suggesting that EphB3 may regulate synaptic formation or 
maintenance during development. For this reason, CCI injury values were only compared to 
sham controls of their respective genotype. Interestingly, we did not observe injury-induced 
synaptic losses in CCI injured EphB3−/− mice as compared to EphB3−/− sham controls (Fig. 
3F).
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In addition to overt synaptic loss in WT mice, CCI injury could also lead to disorganization 
of subsisting synapses, interruption of glutamatergic signaling scaffolds and impaired 
excitatory signaling (Carlson et al., 2015; Luo et al., 2011, 2014). Thus, we next quantified 
the average area of both pre- and post-synaptic density (SD) at 7 dpi in sham and CCI 
injured WT and EphB3−/− mice. We observed no significant difference in the area of pre-SD 
and post-SD between WT sham and CCI injured mice (Fig. 3G, H), suggesting that 
remaining synapses are possibly stabilized within the first week. We did observe a 
significant increase (p < 0.001) in the post-SD area in EphB3−/− sham mice compared with 
WT sham mice (Fig. 3G). However, in the hippocampus of EphB3−/− mice, CCI injury lead 
to significantly less (p = 0.0023) area covered by the post-SD protein network in the absence 
of synaptic loss (Fig. 3G), suggesting that EphB3 may play deleterious roles in synaptic 
maintenance after CCI injury.
To further evaluate synaptic densities, we examined the distribution of synaptic density size 
between groups (Fig. 3I, J). Post-SD areas showed a left-modal distribution that ranged from 
0 to 11,000 nm2 for sham-and CCI-injured WT and EphB3−/− synapses (Fig. 3I). The overall 
distribution of synaptic densities was evaluated using a Kolmogorov– Smirnov (KS) test, 
which showed significant variance between the distribution of WT versus EphB3−/− sham (p 
< 0.001) and between EphB3−/− sham versus EphB3−/− CCI injured post-SD areas (p < 
0.001). However, no significant differences were observed between groups at any specific 
area using two-way repeated measures ANOVA. Pre-SD areas also showed a left-modal 
distribution ranging from 0 to 5400 nm2 for sham- and CCI-injured WT and EphB3−/− 
synapses (Fig. 3J). KS tests did not show significant difference between sham groups or 
sham versus CCI injury within genotypes. These findings confirm that changes observed in 
pre- and post-SD areas (Fig. 3G – H) were due to a shift in the overall sizes of the synaptic 
densities.
We also evaluated the variability in spine size based on average post-SD diameters, which 
may differ from increased protein aggregation area (Martone et al., 1999). Examination of 
post-SD diameters showed no difference in average diameter between groups (Fig. 3K); 
however, analysis of cumulative distributions did show significant difference between groups 
using KS test. Specifically, we observed a significant difference between EphB3−/− sham 
versus EphB3−/− CCI injury (p = 0.0053). Two-way repeated measures ANOVA showed 
significant interactions between diameter and group, where the Bonferroni post-hoc test 
showed significant difference (p < 0.01) between EphB3−/− sham and EphB3−/− CCI injury 
at diameters ranging between 0.21 and 0.25 µm (SFig. 2A).
To better evaluate the synaptic unit, we next examined the relationship between post-SD and 
pre-SD areas (i.e. post-SD:pre-SD ratio), since a synchronous change in spine size is 
necessary for enhancements in synaptic strength (Meyer et al., 2014). We observed reversed 
trends between WT and EphB3−/− ratios after CCI injury, where WT ratios increased 
significantly (p = 0.0084) while EphB3−/− ratios reduced significantly (p < 0.001) (Fig. 3L – 
P). Examination of cumulative distributions showed group differences between WT sham 
versus EphB3−/− sham (p = 0.0105), WT sham versus WT CCI injury (p = 0.0024), and 
EphB3−/− sham versus EphB3−/− CCI injury (p < 0.001). Two-way repeated measures 
ANOVA of frequency distributions by ratio size showed no significant interaction between 
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ratio and group (SFig. 2B). These findings suggest that reduced synaptic function and 
behavioral deficits inWT CCI injured mice may be associated with overall synaptic loss as 
well as dysregulation of the synaptic unit within the remaining synapses.
3.4. Absence of EphB3 signaling improves synaptic plasticity after CCI injury
To determine whether synaptic function is affected by the EphB3-dependent ultrastructural 
changes after CCI injury, we examined CA3-CA1 hippocampal field excitatory postsynaptic 
potentials (fEPSPs) in vivo in the presence and absence of EphB3 (Fig. 4; n = 4–6/group). 
To assess basal synaptic transmission we recorded input-output (I/O) curves at increasing 
stimulus intensities, and observed no significant interaction among animal groups and 
stimulus intensities (Fig. 4A); however, we did observe significant differences in fEPSP 
slope at different stimulus intensities (p < 0.0001) and between animal groups (p = 0.0132). 
As we observed in our initial characterization of our CCI injury model, WT mice subjected 
to CCI injury exhibit a significant downward shift in the I/O curve at higher stimulus 
intensities. Conversely, when we measured the I/O curves in EphB3−/− mice, we observed no 
significant difference in synaptic recruitment after CCI injury compared to sham (Fig. 4A). 
Examination of paired pulse facilitation (PPF), a measure of presynaptic function, revealed 
no significant differences between animal groups (Fig. 4B). These findings are consistent 
with our in vitro hippocampal slice recordings (SFig. 3A) and corroborate our ultrastructural 
data that the effects observed after CCI injury are mainly post-synaptic in nature. Finally, 
examination of long-term potentiation (LTP) in vivo at the CA1 hippocampal synapse 
showed a significant interaction between animal group and time (p < 0.0001) and main 
effect for animal groups (p = 0.0131) and time (p < 0.0001) (Fig. 4C). Analysis of fEPSP 
slope post-HFS (high frequency stimulation) revealed significant reductions in both early 
and late LTP in WT CCI injured mice (p = 0.0075 and p = 0.0064, respectively) that were 
not observed in EphB3−/− CCI injured mice when compared to genotype-matched shams 
(Fig. 4C – E). Similarly, recordings from hippocampal slices harvested at 7 dpi from CCI 
injured WT mice showed reductions in fEPSP slope, but not in slices from CCI injured 
EphB3−/− mice (SFig. 3B – D). These findings support a deleterious role of EphB3 in 
synaptic function after CCI injury.
3.5. Absence of EphB3 signaling results in improved hippocampal learning after CCI injury
We next examined hippocampal-dependent learning and memory using a fear-conditioning 
paradigm. Following injury, WT and EphB3−/− mice were habituated at 5 dpi, trained at 6 
dpi and tested for freezing behavior at 7 dpi. No significant differences were observed 
between sham and CCI or between genotypes during training periods (Fig. 5; n = 8–15/
group). During the contextual testing period, we observed a main effect for animal groups (p 
< 0.0001). CCI injury led to a significant (p < 0.0001)~50% reduction in contextual and 
cued freezing behavior in WT CCI injured mice when compared with WT sham mice. 
Contrarily, EphB3−/− CCI injured mice performed statistically similar to sham controls in 
both contextual and cued learning paradigms, although a trend towards reduced performance 
after injury was observed, possibly due to extra-hippocampal damage following CCI injury. 
These findings support our electrophysiological recordings that suggest activation of EphB3 
may exacerbate injury-induced deficits in hippocampal function.
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3.6. EphB3 does not affect injury-induced changes in hippocampal synaptic proteins
To investigate the molecular basis of the changes in synaptic plasticity observed in CCI-
injured hippocampal neurons in the presence and absence of EphB3, we examined the 
expression of key synaptic proteins essential for excitatory synaptic transmission. 
Specifically, we quantified protein levels for post-synaptic glutamatergic receptor subunits 
(i.e. GluR1, NR1 and NR2B) and synaptosomal-associated protein-23 (SNAP23) and −25 
(SNAP25) in sham and CCI injured whole hippocampal tissues at 7 dpi using Western blot 
analysis (Fig. 6; n = 4/group). We observed stable levels of the AMPAR subunit GluR1 
regardless of genotype or injury state (Fig. 6A). The NMDAR subunits NR1 and NR2B 
contribute to hippocampal learning and memory as well as injury-induced excitotoxicity 
(Gambrill and Barria, 2011; Paoletti et al., 2013). NR1 subunits, the site for D-serine 
binding, showed no significant differences from sham controls for either genotype (Fig. 6B). 
In WT mice we observed a significant increase in NR2B levels after CCI injury (p = 0.0293) 
that was also observed in EphB3−/− mice as compared with their respective sham controls (p 
= 0.0159) (Fig. 6C). We also examined SNARE complex proteins, SNAP-25 and SNAP-23, 
involved in neuronal and astrocytic vesicular release, respectively. We did not observe 
significant differences in SNAP-25 nor SNAP-23 levels after CCI injury for either WT or 
EphB3−/− mice (Fig. 6D, E). Finally, since increased glial fibrillary acidic protein (GFAP) 
levels are a hallmark of reactive astroctyes after brain injury, we examined whether WT and 
EphB3−/− mice showed differences in GFAP expression at 7 dpi. Similar increases in GFAP 
immunoreactivity were observed between WT (p = 0.0003) and EphB3−/− (p = 0.0002) mice 
(Fig. 6F). Together, these findings suggest that significant variances in core synaptic proteins 
do not underlie the functional differences observed between WT and EphB3−/− mice after 
CCI injury.
3.7. EphB3 regulates D-serine but not glutamate levels after CCI injury
We had previously shown that EphB3 can regulate D-serine levels in the naïve brain (Zhuang 
et al., 2010), while others have shown D-serine can exacerbate excitotoxic effects of NMDA 
hyper-activation after injury (Katsuki et al., 2004; Shleper et al., 2005). Therefore, we 
analyzed transmitter levels in sham and CCI injured whole hippocampi in the presence and 
absence of EphB3 using a chemiluminescent assay (Fig. 7; n = 6–7/group). In the WT 
hippocampus during the acute CCI injury period, the D-serine levels increased at 4 and 24 h 
post-CCI injury (hpi) as compared with sham controls (p = 0.0032 and p = 0.034, 
respectively; Fig. 7A), but returned to baseline by 3 dpi and were maintained for at least 7 
dpi (not shown). Examination of glutamate levels at the same time points showed no 
significant difference in WT CCI injured tissues compared to WT sham controls (Fig. 7B), 
and these basal levels were also maintained for at least 7 dpi (not shown). When we 
compared the level of D-serine in EphB3−/− shams, we observed no significant difference 
from WT shams. Strikingly, in the CCI injured EphB3−/− hippocampus, D-serine levels were 
not increased at 4 and 24 hpi (Fig. 7A).
Next, we examined whether ephrinB3 stimulation of Eph signaling would augment D-serine 
or glutamate levels in WT mice at 3 dpi, a time when transmitter levels have returned to 
baseline. Infusion of clustered ephrinB3-Fc (112 µg/kg/day) for 3 days into the ipsilateral 
hippocampus resulted in a significant increase in D-serine levels in hippocampi from WT 
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mice but not EphB3−/−/EphA4−/− double knockout mice (Fig. 7C). EphB3−/−/EphA4−/− 
mice where used to eliminate potential off target interactions with ephrinB3. Control anti-
human-Fc molecules showed no effect on D-serine levels as compared to non-infused naïve 
or sham mice. Furthermore, application of clustered ephrinB3-Fc did not alter glutamate 
levels in either WT or EphB3−/−/ EphA4−/− mice (Fig. 7D).
3.8. Increased D-serine can reverse the enhanced synaptic plasticity observed in EphB3−/− 
mice after CCI injury
To validate our conclusion that CCI injury-induced synaptic dysfunction is aggravated by 
EphB3 regulation of D-serine levels, we examined CA3-CA1 hippocampal fEPSPs in vivo in 
CCI injured EphB3−/− mice after vehicle or D-serine (840 µg/kg/day) infusion (Fig. 8; n = 6/ 
group). We infused D-serine or vehicle into the contralateral ventricle for 3 days after CCI 
injury. EphB3−/− mice that received D-serine infusion demonstrated reduced basal synaptic 
transmission revealed by a downward shifted I/O curve at stimulation intensities of 20 µA or 
higher compared with vehicle-infused controls (Fig. 8A). Two-way repeated measures 
ANOVA showed significant interaction between groups and stimulus intensity (p < 0.0001), 
where the Bonferroni post-hoc test showed significant difference between CCI injured 
EphB3−/− vehicle-and D-serine-treated mice (p < 0.001). No significant differences were 
observed in PPF between groups (Fig. 8B); however, significant differences were observed 
in LTP. Specifically, we observed a significant interaction between groups and time(p < 
0.0001) and main effect for animal groups (EphB3−/− CCI-injured vehicle- vs. D-serine-
infused; p = 0.0087) and time (p < 0.0001) (Fig. 8C). Analysis of fEPSP slope post-HFS 
revealed that D-serine infusion resulted in significant reductions in both early and late LTP in 
EphB3−/− CCI injured mice when compared with vehicle-infused mice (p < 0.0001; Fig. 8C 
– E). These findings support our observations that increased D-serine levels in the 
hippocampus are detrimental to synaptic function, and that EphB3 signaling may regulate 
synaptic dysfunction after CCI injury through enhanced D-serine synthesis and release.
4. Discussion
Synaptic dysfunction and impaired plasticity can have a significant impact on motor, sensory 
and cognitive functions in TBI patients. Neuronal cell death is a predominant underlying 
cause for synaptic loss in regions of tissue damage; however, synaptic dysfunction is also 
present in more distal brain regions where neuronal loss is not observed (Lyeth et al., 1990). 
To begin to examine synaptic dysfunction within the complex and evolving TBI 
environment, we have developed a moderate CCI injury model that leads to hippocampal 
synaptic damage without neuronal losses. We then examined the role of ephrins and Eph 
receptors in synaptic stability and function after TBI. In the CCI injured hippocampus, we 
found that EphB3−/− mice showed stable numbers of synapses compared to sham controls, 
and improved synaptic plasticity and learning behavior as compared with WT CCI injured 
mice. Comparison of key synaptic proteins essential for excitatory synaptic transmission 
showed no differences between WT and EphB3−/− mice; however, increases in the NMDAR 
co-agonist D-serine following CCI injury were significantly reduced in the absence of 
EphB3. Furthermore, rescuing D-serine levels in EphB3−/− mice could recapitulate the 
synaptic deficits observed in WT CCI injured mice. These findings suggest that elevated D-
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serine levels in the hippocampus may play deleterious roles by destabilizing synapses after 
TBI, and are in part regulated by ephrin-EphB3 signaling.
Our observation that CCI injury results in approximately 20% synaptic losses, and >50% 
reduction in LTP and learning in the first week suggests that synaptic loss and dysfunction 
together may underlie the observed functional deficits. Our observed losses in excitatory 
synapses in the mouse hippocampus are less pronounced than the ~50% reduction in CA1 
synapses in rats after CCI injury (Scheff et al., 2005). This discrepancy could be attributed to 
species-specific effects but also a higher injury severity, which also lead to CA3 pyramidal 
cell death. Alternatively, changes in synaptic size and morphology may also contribute to 
functional deficits (Carlson et al., 2015; Gao et al., 2011; Marrone et al., 2004). After injury 
the main difference observed was an increase in the ratio between post-SD to pre-SD area in 
WT mice. This could be due to spine enlargement, a reduction of presynaptic bouton size, or 
a combination of both. However, the opposite effect was observed in the synaptic unit of 
EphB3−/− mice after injury. When taken together with the deficits in hippocampal function 
observed, these findings suggest that synchronous changes in both elements of synapse 
morphology are important for structural stabilization and plasticity (Meyer et al., 2014). 
Furthermore, excess activation by increased levels of D-serine could be participating in 
destabilizing the synapse and causing synaptic damage (Shleper et al., 2005).
Alterations in the levels of different synaptic proteins have also been associated with deficits 
in synaptic plasticity after TBI (Osteen et al., 2004; Spaethling et al., 2012; Titus et al., 
2013). The co-agonist binding site for D-serine is located on NR1 subunits (Johnson and 
Ascher, 1987; Mothet et al., 2000). Interestingly, NR1 protein levels did not change after 
CCI injury for either group, suggesting that increase in D-serine after injury leads to increase 
binding probability (Furukawa and Gouaux, 2003) and could enhance NMDA-dependent 
glutamatergic signaling. In the CCI injured hippocampus, we observed increased levels of 
the NR2B subunit of the NMDAR in bothWT and EphB3−/− mice, which has been shown to 
be associated with extra-synaptic NMDARs and the detrimental effects of NMDAR over-
activation (Bading et al., 1993; Hardingham and Bading, 2010; Hardingham et al., 2002). 
Regulation of NMDARs after injury seems to be temporally dependent and differs between 
injury models (Giza et al., 2006; Hsu et al., 1998; Kumar et al., 2002; Osteen et al., 2004; 
Schumann et al., 2008; Small et al., 1997). In more severe models, an acute transient 
reduction in NR2B levels is followed by protein up-regulation at later periods (Brown et al., 
2004; Kumar et al., 2002), while no difference is observed in less severe models (Giza et al., 
2006; Osteen et al., 2004). Despite these discrepancies, a shift in the relative amounts of 
synaptic NR2A to extra-synaptic NR2B receptors has been well established to mediate 
damage caused by initial injury (Giza et al., 2006; Osteen et al., 2004; Small et al., 1997), 
and likely contributes to the CCI injury-induced deficits observed in WT mice. However, 
increased NR2B receptors in EphB3−/− mice did not result in synaptic damage or loss, 
suggesting that reductions in the NMDAR co-agonist D-serine likely underlie the reduced 
synaptic damage observed in these mice. EphB receptors have been shown to play roles in 
glutamate receptor activation, trafficking and localization (Antion et al., 2010; Grunwald et 
al., 2004; Henderson et al., 2001; Irie et al., 2005). We cannot rule out that in EphB3 
deficient mice NR2B receptors may remain in the cytoplasm, are unable to become 
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incorporated into the extra-synaptic membranes and do not contribute to detrimental effects 
of over-activation.
Since our model of CCI injury did not involve hippocampal neuron loss, it suggests that 
neuronal excitotoxicity may be below the apoptotic threshold in the hippocampus. It is well 
accepted that glutamate excitotoxicity results from an acute release of glutamate from 
neurons within the first minutes after trauma, and leads to excessive calcium influx through 
over-activation of NMDARs, initiation of pro-apoptotic signaling cascades, and ultimately 
neuronal damage (Faden et al., 1989; Obrenovitch and Urenjak, 1997). While this likely 
occurs in the cortex in our model, we did not observe neuronal loss in the hippocampus even 
at regions directly ventral to the injury epicenter. Furthermore, there was no significant 
difference in total hippocampal glutamate levels at 4 h post-injury (hpi), a time-point where 
glutamate levels have returned to baseline (Obrenovitch and Urenjak, 1997) and the earliest 
time-point we tested. Conversely, the NMDAR co-agonist D-serine is up-regulated hours to 
days after CCI injury and contributes to synaptic damage but not cell death. Enhanced D-
serine levels have also been observed in other peripheral and CNS injury models (Lin et al., 
2015; Moon et al., 2015). Moreover, pharmacological reductions in D-serine levels have been 
shown to protect neurons from excitotoxic insult (Hama et al., 2006; Shleper et al., 2005). In 
the absence of EphB3, increased D-serine levels were not observed after CCI injury. This 
provides support to our previous gain-of-function studies showing that ephrinB3 stimulation 
of EphB3 could increase D-serine levels in hippocampal slices and cultured astrocytes 
(Zhuang et al., 2010). Excessive D-serine levels can induce synaptic damage and reverse the 
rescue effects associated with the absence of EphB3 after CCI injury; however, the addition 
of D-serine by itself was not sufficient to induce NMDA-mediated synaptic damage in 
hippocampal slices (Katsuki et al., 2004). Together, these findings support a role for EphB3 
signaling in regulating D-serine levels as a novel mechanism by which EphB3 receptors can 
potentiate damage in the traumatic injured brain. Additional studies are needed to determine 
how these effects are mediated by EphB3 signaling and establish if D-serine release is from 
neurons and/or astrocytes.
TBI patients typically live with life-long cognitive impairment even in the absence of 
significant tissue pathology (Barth et al., 1983; Gualtieri and Cox, 1991; McAllister et al., 
1999). To date, most neuroprotective strategies have focused on preserving cell survival, 
preventing glutamate excitotoxicity, and inhibiting secondary inflammatory responses 
(Beauchamp et al., 2008; Corps et al., 2015). Our findings suggest that synaptic loss and 
dysfunction may be an important therapeutic target. Understanding the mechanisms 
regulating D-serine and NMDARs contributing to the balance of synaptic stability versus 
dysfunction will have important neuroprotective consequences. Our study suggests Eph 
receptor signaling plays a role in regulating this balance, whereby inhibiting Eph receptor 
signaling could lead to improved synaptic numbers and function after TBI.
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Fig. 1. 
CCI injury model of synaptic dysfunction without hippocampal neuronal losses. 
Hematoxylin and eosin stained tissues showing gross morphological damage 7 dpi after 
sham (A) and CCI (B) injury. Rectangles indicate region for images in A’–B’ and C–D. 
High magnification confocal images of CA1 pyramidal neurons in Thy-1-YFP mice show 
neuronal dendritic densities in sham (A’) and CCI injured (B’) mice. Increased astrocyte 
(GFAP) reactivity and hypertrophy, a hallmark of brain injury, is observed in the CA1 region 
of the after CCI injury (D) as compared with sham (C) mice. (E) Significant downward shift 
in I/O curve of fEPSPs recorded from CA1 stratum radiatum in vivo at increasing intensities 
of stimulation in CCI injured mice as compared with sham mice. Insets show sample fEPSP 
traces for I/O curve. (F) Tetanic high frequency stimulation (HFS) shows enhanced LTP in 
vivo in sham but not CCI injured mice, where fEPSP slopes were normalized to baseline. 
Inset depicts representative pre- and post-HFS traces per group. E and F, sham n = 5 and 
CCI injury n = 4. (G) Significant decrease in percent freezing behavior in CCI mice 
compared with sham mice in both contextual and cued testing (mean ± SEM; n = 7/group). 
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Quantitative cell counts from hematoxylin stained (H) and anti-NeuN immunoreactive (I) 
CA1, CA3, and DGC by non-biased stereology (n = 5/group). All data presented as mean ± 
SEM. *p < 0.05 and ***p < 0.001 compared with sham controls, ^^^p < 0.001 compared 
with habituation. Ctx, cortex; Hipp, hippocampus; CA1, CA1 pyramidal cells; CA3, CA3 
pyramidal cells; DGC, dentate granule cells.
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Fig. 2. 
Increased levels of EphB3 does not affect cell survival in the hippocampus after CCI injury. 
(A) Western blots show increased hippocampal EphB3 protein levels at 3 and 7 dpi in WT 
mice, which were standardized to β-tubulin and normalized to sham (mean ± SEM; n = 4/
group, repeated in triplicate). For full blots see SFig. 4. Hematoxylin and eosin stained 
EphB3−/− sham (B) and CCI (C) injured tissue showing gross morphological damage. (D) 
Number of hippocampal cells within each region in EphB3−/− sham and CCI injured mice 
(mean ± SEM; n = 5/group). *p < 0.05 and **p < 0.01.
Perez et al. Page 22
Neurobiol Dis. Author manuscript; available in PMC 2017 October 31.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 3. 
CCI injury leads to EphB3-dependent synaptic loss and alterations in pre- and post-synaptic 
densities in the hippocampus. (A) Cresyl violet stain of hippocampal tissue, where box 
indicates region within CA1 stratum radiatum selected for sectioning and grid placement. 
(B) Grid numbers represent random sampling fields for image acquisition (scale bar = 500 
µM). (C) Representative 25,000× electron micrograph of CA1 stratum radiatum with EPTA-
stained excitatory synapses (scale bar = 50 µM). High magnification images of synapses 
with asymmetrical pre- and post-SDs (D) and clear, delineated synaptic cleft and pre-
synaptic vesicles (E). (F) CCI injury resulted in a reduction in synaptic numbers in WT, but 
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not EphB3−/− when compared with sham controls. (G) Quantification of mean post-SD area 
showed EphB3−/− shams had increased post-SD area when compared with both WT sham 
and EphB3−/− CCI group. (H) Quantification of mean pre-SD area showed no difference 
between groups. Frequency distribution plots show positively-skewed curve of post-SD area 
(I) and pre-SD area (J). (K) Quantification of mean post-SD diameter showed no significant 
differences between groups. (L) Comparison of the ratio between post-SD to pre-SD areas 
showed opposing CCI injury-induced effects in WT and EphB3−/− mice, where CCI lead to 
an increase in WT ratio and decrease in EphB3−/− ratio. (M–P) Representative synapses for 
each group reflect changes observed in synaptic quantifications. All data presented as mean 
± SEM with n = 4/group with at least 20 micrographs per animal. *p < 0.05, **p < 0.01, 
***p < 0.001 compared with WT sham, and ##p < 0.01; ###p < 0.001 compared with 
EphB3−/− sham.
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Fig. 4. 
Synaptic plasticity is significantly reduced in the hippocampus at 7 dpi in WT but not 
EphB3−/− mice. (A) I/O curve plotting the in vivo hippocampal fEPSP at increasing stimulus 
intensities shows CCI injury in WT mice resulted in a significant downward shift at higher 
stimulus intensities, while no significant difference was observed in the EphB3−/− CCI group 
when compared to EphB3−/− sham group. Inset, superimposed representative traces of 
evoked fEPSPs at increasing current intensities. (B) Examination of PPF, the ratio of second 
fEPSP to the first fEPSP slope, revealed no significant differences between animal groups. 
(C) Examination of LTP, normalized to baseline fEPSP slope, in vivo at the CA1 
hippocampal synapse showed significant CCI injury-induced deficit in WT but not EphB3−/− 
mice. Analysis of fEPSP slope post-HFS revealed that injury resulted in significant 
reductions in both early (D) and late (E) phase LTP in WT CCI mice when compared with 
WT sham mice. No differences were observed between EphB3−/− sham and EphB3−/− CCI-
injured mice for either early or late LTP responses. All data presented as mean ± SEM. WT 
sham, n = 5; WT CCI, n = 4; EphB3−/− sham, n = 6; EphB3−/− CCI, n = 5. *p < 0.05, **p < 
0.01 compared with WT sham.
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Fig. 5. 
Hippocampal learning is significantly reduced at 7 dpi in WT but not EphB3−/− mice. 
Hippocampal-dependent fear-conditioning behavior quantified as percent freezing showed 
no significant differences between sham and CCI and between genotypes at baseline; 
however, a significant decrease in freezing behavior in both contextual and cued learning 
was observed in WT CCI mice when compared with WT sham mice. Nonsignificant 
reductions were observed in EphB3−/− CCI injured mice compared to EphB3−/− sham mice 
in both contextual and cued learning. Data presented as mean ± SEM. WT sham, n = 10; 
WT CCI, n = 15; EphB3−/− sham, n = 10; EphB3−/− CCI, n = 8. ***p < 0.001 compared 
with WT sham.
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Fig. 6. 
CCI-induced alterations in synaptic protein levels are similar in WT and EphB3−/− 
hippocampi at 7 dpi. CCI injury did not result in significant changes in levels of GluR1 (A), 
NR1 (B), SNAP-25 (D) and SNAP-23 (E), but NR2B (C) was upregulated in both WT and 
EphB3−/− mice. (F) GFAP, a marker of reactive astrocytosis, was significantly upregulated 
after CCI with no differences between WT and EphB3−/− CCI groups. Insets, representative 
Western blots for each protein, including beta-tubulin as a loading control. For full blots see 
SFig. 4. All data presented as mean ± SEM; n = 4/group, repeated in triplicate. *p < 0.05, 
**p < 0.01, ***p < 0.001 compared with sham control.
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Fig. 7. 
Eph receptor signaling regulates injury-induced changes in D-serine but not glutamate levels 
in the hippocampus. CCI injury lead to significant increases in total levels of D-serine in WT 
but not EphB3−/− hippocampi at 4 and 24 hpi (A), while no significant changes were 
observed in total glutamate levels (B) at these time points. EphrinB3 stimulation of Eph 
signaling lead to increased levels of D-serine in WT but not EphB3−/−/EphA4−/− mice at 3 
dpi (C), while having no effect on levels of glutamate in both groups of mice (D). All data 
presented as mean ± SEM; A, n = 7/group; B, n = 6/group; C, n = 7/group; D, n = 6/group. 
*p < 0.05, **p < 0.01, ***p < 0.001 compared with WT sham.
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Fig. 8. 
Infusion of D-serine can reverse the enhanced synaptic plasticity observed in EphB3−/− mice 
at 7 dpi. (A) Basal synaptic transmission is diminished after D-serine but not vehicle infusion 
in EphB3−/− mice, as seen by downward shift in I/O curve in current intensities of 20 mA or 
higher. Inset, superimposed representative traces of evoked fEPSPs at increasing current 
intensities. (B) Examination of presynaptic function through PPF revealed no significant 
differences between animal groups. (C–E) A significant reduction in LTP was observed in D-
serine- versus vehicle-treated EphB3−/− mice. Examination of LTP in vivo at the CA1 
hippocampal synapse showed a significant injury-induced deficit in D-serine but not vehicle-
infused EphB3−/− mice (C). Analysis of fEPSP slope post-HFS revealed that injury resulted 
in significant reductions in both early (D) and late (E) phase LTP in D-serine infused 
EphB3−/− mice when compared with vehicle-infused EphB3−/− mice. All data presented as 
mean ± SEM; EphB3−/− CCI + vehicle, n = 6; EphB3−/− CCI + D-serine, n = 6. **p < 0.01, 
***p < 0.001 compared with vehicle-infused group.
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